David Ian Wilson insider trades
Open-market stock purchases and sales by David Ian Wilson, Director at Neuphoria Therapeutics Inc, from SEC Form 4 filings since Apr 16, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 20, 2026 | NEUP Neuphoria Therapeutics Inc | Bought (not open market) | — |
Companies traded
- NEUP Neuphoria Therapeutics Inc: other filings, last Jan 20, 2026